1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Spain Pharmaceuticals and Healthcare Report Q3 2016

Spain Pharmaceuticals and Healthcare Report Q3 2016

  • June 2016
  • -
  • Business Monitor International
  • -
  • 82 pages

Includes 3 FREE quarterly updates

BMI View: Growth in the Spanish pharmaceutical market will remain slow but steady, despite being aneconomic outperformer in Western Europe. The ageing population of Spain, and the wider Europe region,will create significant revenue earning opportunities for drugmakers. However, as populations age, theeffective economic old-age dependency ratio is also projected to rise sharply. This will place pressures ongovernment budgets and the funds available for welfare spending, including expenditure onpharmaceuticals and healthcare.

Headline Expenditure Projections

- Pharmaceuticals: EUR25.18bn (USD27.93bn) in 2015 to EUR25.62bn (USD27.42bn) in 2016;+1.7% in local currency terms and -1.8% in US dollar terms. Forecast in line with last quarter.

- Healthcare: EUR93.98bn (USD104.23bn) in 2015 to EUR95.18bn (USD101.84bn) in 2016; +1.3% inlocal currency terms and -2.3% in US dollar terms. Forecast revised upwards slightly from last quarter.

Table Of Contents

Spain Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Spain 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Spain 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Spain 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Spain 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Spain 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Spain 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Spain 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Spain 2012-2020) 25
OTC Drug Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Spain 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Spain 2014-2020) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Spain 2014-2020) 29
Pharmaceuticals and Healthcare Risk/Reward Index 30
Western Europe Risk/Reward Index 30
Spain Risk/Reward Index 35
Rewards 35
Risks 35
Regulatory Review 37
Intellectual Property Issues 38
Parallel Trade 39
OTC Medicines 40
Generic Medicines 41
Pricing Regime 41
Reference Pricing System 43
Reimbursement Regime 46
Market Overview 47
Healthcare Sector 48
Table: Regional Public Hospital Debt - Values In EURmn 49
Table: Healthcare Resources (Spain 2010-2015) 51
Table: Healthcare Personnel (Spain 2010-2015) 51
Table: Healthcare Activity (Spain 2010-2015) 52
Research and Development 52
Clinical Trials 53
Epidemiology 55
Competitive Landscape 57
Research Based Industry 57
Table: Multinational Market Activity 58
Generic Drug Sector 59
Biotechnology Sector 61
Pharmaceutical Retail 62
Company Profile 65
Almirall 65
Esteve 68
Demographic Forecast 71
Demographic Outlook 71
Table: Population Headline Indicators (Spain 1990-2025) 72
Table: Key Population Ratios (Spain 1990-2025) 72
Table: Urban/Rural Population and Life Expectancy (Spain 1990-2025) 73
Table: Population By Age Group (Spain 1990-2025) 73
Table: Population By Age Group % (Spain 1990-2025) 74
Glossary 76
Methodology 78
Pharmaceutical Expenditure Forecast Model 78
Healthcare Expenditure Forecast Model 78
Notes On Methodology 79
Risk/Reward Index Methodology 80
Index Overview 81
Table: Pharmaceutical Risk/Reward Index Indicators 81
Indicator Weightings 82

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.